Recent Quotes

Trinity Biotech PLC is in the business of development, manufacture, and marketing of clinical diagnostic products for clinical laboratory and point of care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Premier, Immublot, EZ, Capita, and others. Geographically, it has two segments namely the Americas and Rest of World of which it derives a majority of its revenues from the Americas segment.

Earnings

Q1 2021		Est.		Actual		Surprise
EPS		0.070		0.101		0.0310
REV		24.000M		25.594M		1.594M

Q4 2020		Est.		Actual		Surprise
EPS		0.140		0.360		0.2200
REV		28.000M		32.765M		4.765M

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Related Companies

Ticker	Company	Price	Change	Chg %		Mkt Cap
TRIB	Trinity Biotech	2.80	-0.07	-2.44%		60M

Trinity Biotech Frequently Asked Questions

How do I buy Trinity Biotech (TRIB) stock?

You can purchase shares of Trinity Biotech (NASDAQ: TRIB) through any online brokerage.

View our list of the best stock brokerages.

Who are Trinity Biotech's (TRIB) competitors?

Other companies in Trinity Biotech’s space includes: ENDRA Life Sciences (NASDAQ:NDRA), Pro-Dex (NASDAQ:PDEX), LENSAR (NASDAQ:LNSR), Motus GI Hldgs (NASDAQ:MOTS) and NeuroOne Medical Tech (NASDAQ:NMTC).

What is the target price for Trinity Biotech (TRIB) stock?

The latest price target for Trinity Biotech (NASDAQ: TRIB) was reported by Stephens & Co. on October 5, 2016. The analyst firm set a price target for 0.00 expecting TRIB to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

Current Stock Price for Trinity Biotech (TRIB)?

The stock price for Trinity Biotech (NASDAQ: TRIB) is $2.87 last updated Wed Jun 23 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Does Trinity Biotech (TRIB) pay a dividend?

There are no upcoming dividends for Trinity Biotech. The last dividend paid out to investors was $0.00 on June 5, 2015.

When is Trinity Biotech (NASDAQ:TRIB) reporting earnings?

Trinity Biotech’s Q2 earnings are confirmed for after-market on August 24, 2021.

Is Trinity Biotech (TRIB) going to split?

There is no upcoming split for Trinity Biotech.

What sector and industry does Trinity Biotech (TRIB) operate in?

Trinity Biotech is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.